IGMS
Price
$1.27
Change
-$0.01 (-0.78%)
Updated
Jul 25 closing price
Capitalization
76.44M
15 days until earnings call
MRVI
Price
$2.69
Change
-$0.02 (-0.74%)
Updated
Jul 25 closing price
Capitalization
387.29M
16 days until earnings call
Interact to see
Advertisement

IGMS vs MRVI

Header iconIGMS vs MRVI Comparison
Open Charts IGMS vs MRVIBanner chart's image
IGM Biosciences
Price$1.27
Change-$0.01 (-0.78%)
Volume$108.76K
Capitalization76.44M
Maravai LifeSciences Holdings
Price$2.69
Change-$0.02 (-0.74%)
Volume$886.56K
Capitalization387.29M
IGMS vs MRVI Comparison Chart in %
Loading...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IGMS vs. MRVI commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGMS is a Hold and MRVI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (IGMS: $1.27 vs. MRVI: $2.69)
Brand notoriety: IGMS and MRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IGMS: 17% vs. MRVI: 50%
Market capitalization -- IGMS: $76.44M vs. MRVI: $387.29M
IGMS [@Biotechnology] is valued at $76.44M. MRVI’s [@Biotechnology] market capitalization is $387.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IGMS’s FA Score shows that 0 FA rating(s) are green whileMRVI’s FA Score has 1 green FA rating(s).

  • IGMS’s FA Score: 0 green, 5 red.
  • MRVI’s FA Score: 1 green, 4 red.
According to our system of comparison, MRVI is a better buy in the long-term than IGMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IGMS’s TA Score shows that 4 TA indicator(s) are bullish while MRVI’s TA Score has 4 bullish TA indicator(s).

  • IGMS’s TA Score: 4 bullish, 5 bearish.
  • MRVI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both IGMS and MRVI are a bad buy in the short-term.

Price Growth

IGMS (@Biotechnology) experienced а -0.78% price change this week, while MRVI (@Biotechnology) price change was +10.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

IGMS is expected to report earnings on Nov 06, 2025.

MRVI is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRVI($387M) has a higher market cap than IGMS($76.4M). MRVI YTD gains are higher at: -50.642 vs. IGMS (-79.214). IGMS has higher annual earnings (EBITDA): -178.4M vs. MRVI (-190.13M). MRVI has more cash in the bank: 285M vs. IGMS (152M). IGMS has less debt than MRVI: IGMS (44M) vs MRVI (371M). MRVI has higher revenues than IGMS: MRVI (242M) vs IGMS (2.68M).
IGMSMRVIIGMS / MRVI
Capitalization76.4M387M20%
EBITDA-178.4M-190.13M94%
Gain YTD-79.214-50.642156%
P/E RatioN/AN/A-
Revenue2.68M242M1%
Total Cash152M285M53%
Total Debt44M371M12%
FUNDAMENTALS RATINGS
IGMS: Fundamental Ratings
IGMS
OUTLOOK RATING
1..100
46
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IGMSMRVI
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 17 days ago
79%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBNNF0.20N/A
N/A
PT Bank Negara Indonesia TBK
ANZLY1.69N/A
N/A
Air New Zealand Ltd.
JFWV108.00N/A
N/A
JSB Financial Inc.
BECEF13.10N/A
N/A
BCE Inc.
CJREF0.07N/A
-5.20%
Corus Entertainment, Inc.

IGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with MRSN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then MRSN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
-0.78%
MRSN - IGMS
53%
Loosely correlated
-4.19%
CRNX - IGMS
47%
Loosely correlated
N/A
DYN - IGMS
46%
Loosely correlated
+7.68%
MDGL - IGMS
42%
Loosely correlated
-0.26%
APLS - IGMS
40%
Loosely correlated
-2.49%
More

MRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRVI has been loosely correlated with CRDF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MRVI jumps, then CRDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRVI
1D Price
Change %
MRVI100%
-0.74%
CRDF - MRVI
40%
Loosely correlated
-3.86%
TECH - MRVI
38%
Loosely correlated
+0.53%
AXON - MRVI
34%
Loosely correlated
+3.63%
VCYT - MRVI
33%
Loosely correlated
+7.04%
IGMS - MRVI
31%
Poorly correlated
-0.78%
More